215 related articles for article (PubMed ID: 37306722)
21. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
[TBL] [Abstract][Full Text] [Related]
22. Novel three-way fusions among ZNF384, EWSR1 and EHMT1 genes in paediatric B cell precursor acute lymphoblastic leukaemia with translocations resembling Philadelphia chromosomes.
Chen X; Wang F; Cao P; Zhang Y; Ma X; Liu M; Teng W; Yang J; Zhang J; Wang T; Liu H
Br J Haematol; 2019 Nov; 187(3):e75-e79. PubMed ID: 31531845
[No Abstract] [Full Text] [Related]
23. Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR-ABL1, KMT2A rearrangement, and other adult B-cell precursor acute lymphoblastic leukemia.
Wang YZ; Qin YZ; Chang Y; Yuan XY; Chen WM; He LL; Hao L; Shi WH; Jiang Q; Jiang H; Huang XJ; Liu YR
Cytometry B Clin Cytom; 2022 Sep; 102(5):360-369. PubMed ID: 35735203
[TBL] [Abstract][Full Text] [Related]
24. Interaction partners for human ZNF384/CIZ/NMP4--zyxin as a mediator for p130CAS signaling?
Janssen H; Marynen P
Exp Cell Res; 2006 Apr; 312(7):1194-204. PubMed ID: 16510139
[TBL] [Abstract][Full Text] [Related]
25. t(12;17)(p13;q12)/TAF15-ZNF384 Rearrangement in Acute Lymphoblastic Leukemia.
Kim J; Kim HS; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 Jul; 36(4):396-8. PubMed ID: 27139620
[No Abstract] [Full Text] [Related]
26. Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion.
Ping N; Qiu H; Wang Q; Dai H; Ruan C; Ehrentraut S; Drexler HG; MacLeod RA; Chen S
J Hematol Oncol; 2015 Aug; 8():100. PubMed ID: 26293203
[TBL] [Abstract][Full Text] [Related]
27. Acute lymphoblastic leukemia with infrequent ARID1B::ZNF384 gene fusion simulating multifocal osteomyelitis.
Long F; Li T; Zhang Y; Gao X; Wang H; Huang X
Pediatr Blood Cancer; 2023 Oct; 70(10):e30514. PubMed ID: 37336773
[No Abstract] [Full Text] [Related]
28. [Identification of TCF3-ZNF384 fusion by transcriptome sequencing in B cell acute lymphoblastic leukemia and its laboratory and clinical characteristics].
Wu Q; Wang F; Yang J; Chen X; Ma X; Cao P; Zhang Y; Nie D; Chen J; Zhou X; Fang J; Liu M; Zhang M; Wu P; Wang T; Liu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Apr; 38(4):351-354. PubMed ID: 33834463
[TBL] [Abstract][Full Text] [Related]
29. Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia.
Wu Z; Zhang F; Liu C; Shen S; Chu J; Yang L; Xie Z; Liu Y; Liu K; Wang N
Front Oncol; 2022; 12():900054. PubMed ID: 36052266
[TBL] [Abstract][Full Text] [Related]
30. A Rare Case Report of B-Cell Acute Lymphoblastic Leukemia with EP300::ZNF384 Fusion Gene.
Wu X; Yang X; Chen Y; Zhang Z; XinhongYang
Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868890
[No Abstract] [Full Text] [Related]
31. A novel class of ZNF384 aberrations in acute leukemia.
Zaliova M; Winkowska L; Stuchly J; Fiser K; Triska P; Zwyrtkova M; Hrusak O; Starkova J; Sramkova L; Stary J; Trka J; Zuna J
Blood Adv; 2021 Nov; 5(21):4393-4397. PubMed ID: 34529760
[TBL] [Abstract][Full Text] [Related]
32. A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.
Gocho Y; Kiyokawa N; Ichikawa H; Nakabayashi K; Osumi T; Ishibashi T; Ueno H; Terada K; Oboki K; Sakamoto H; Shioda Y; Imai M; Noguchi Y; Arakawa Y; Kojima Y; Toyama D; Hata K; Yoshida T; Matsumoto K; Kato M; Fukushima T; Koh K; Manabe A; Ohara A;
Leukemia; 2015 Dec; 29(12):2445-8. PubMed ID: 25943178
[No Abstract] [Full Text] [Related]
33. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.
Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M
Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810
[TBL] [Abstract][Full Text] [Related]
34. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract][Full Text] [Related]
35. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
36. The Prognostic Significance of
Qin YZ; Jiang Q; Xu LP; Wang Y; Jiang H; Dao FT; Chen WM; Zhao XS; Liu YR; Zhang XH; Liu KY; Huang XJ
Front Oncol; 2021; 11():632532. PubMed ID: 33816270
[TBL] [Abstract][Full Text] [Related]
37. ZNF384 rearrangement in acute lymphocytic leukemia with renal involvement as the first manifestation is associated with a poor prognosis: a case report.
Ma J; Guan J; Chen B
Mol Cytogenet; 2022 Feb; 15(1):4. PubMed ID: 35164825
[TBL] [Abstract][Full Text] [Related]
38. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
Pottier N; Yang W; Assem M; Panetta JC; Pei D; Paugh SW; Cheng C; Den Boer ML; Relling MV; Pieters R; Evans WE; Cheok MH
J Natl Cancer Inst; 2008 Dec; 100(24):1792-803. PubMed ID: 19066270
[TBL] [Abstract][Full Text] [Related]
39. Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia.
Lee DW; Zhang K; Ning ZQ; Raabe EH; Tintner S; Wieland R; Wilkins BJ; Kim JM; Blough RI; Arceci RJ
Cancer Res; 2000 Jul; 60(13):3612-22. PubMed ID: 10910076
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
